Regulation of transforming growth factor-β1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3

Yanan Yang, Xinchao Pan, Weiwei Lei, Jun Wang, Jian Shi, Fuqiang Li, Jianguo Song

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Apoptosis and epithelial-to-mesenchymal transdifferentiation or transition (EMT) are crucial for normal development and body homeostasis. The alterations of these events are closely related to some pathologic processes, such as tumor formation and metastasis, fibrotic diseases of liver and kidney, and abnormal development of embryos. The mechanism that underlies the simultaneously occurring apoptosis and EMT induced by transforming growth factor-β (TGF-β) has not been well studied. In this report, we investigated the potential mechanism that underlies TGF-β1-induced apoptosis and EMT. TGF-β1-induced apoptosis and EMT were associated with the activation of protein kinase A (PKA) and signal transducers and activators of transcription 3 (STAT3). Inhibition of PKA by specific PKA inhibitor H89 or by PKA inhibitor peptide blocked STAT3 activation and suppressed TGF-β1-induced apoptosis and EMT. Furthermore, overexpression of a phosphorylation-deficient form of STAT3, but not wild-type STAT3, produced an inhibitory effect on TGF-β1-induced apoptosis and EMT. The results indicate that PKA is an upstream regulator for TGF-β1-induced STAT3 activation and plays an important role in TGF-β1-mediated apoptosis and EMT. These studies provided a new insight into the signaling mechanism underlying the apoptosis and EMT, which could be of importance in understanding some related physiologic and pathologic processes.

Original languageEnglish (US)
Pages (from-to)8617-8624
Number of pages8
JournalCancer Research
Volume66
Issue number17
DOIs
StatePublished - Sep 1 2006

Fingerprint

STAT3 Transcription Factor
Epithelial-Mesenchymal Transition
Transforming Growth Factors
Cyclic AMP-Dependent Protein Kinases
Apoptosis
Pathologic Processes
Transcriptional Activation
Kidney Diseases
Protein Kinase Inhibitors
Embryonic Development
Liver Diseases
Homeostasis
Phosphorylation
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Regulation of transforming growth factor-β1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. / Yang, Yanan; Pan, Xinchao; Lei, Weiwei; Wang, Jun; Shi, Jian; Li, Fuqiang; Song, Jianguo.

In: Cancer Research, Vol. 66, No. 17, 01.09.2006, p. 8617-8624.

Research output: Contribution to journalArticle

@article{377a5d2f7e7e406dbc3068dac5dda1db,
title = "Regulation of transforming growth factor-β1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3",
abstract = "Apoptosis and epithelial-to-mesenchymal transdifferentiation or transition (EMT) are crucial for normal development and body homeostasis. The alterations of these events are closely related to some pathologic processes, such as tumor formation and metastasis, fibrotic diseases of liver and kidney, and abnormal development of embryos. The mechanism that underlies the simultaneously occurring apoptosis and EMT induced by transforming growth factor-β (TGF-β) has not been well studied. In this report, we investigated the potential mechanism that underlies TGF-β1-induced apoptosis and EMT. TGF-β1-induced apoptosis and EMT were associated with the activation of protein kinase A (PKA) and signal transducers and activators of transcription 3 (STAT3). Inhibition of PKA by specific PKA inhibitor H89 or by PKA inhibitor peptide blocked STAT3 activation and suppressed TGF-β1-induced apoptosis and EMT. Furthermore, overexpression of a phosphorylation-deficient form of STAT3, but not wild-type STAT3, produced an inhibitory effect on TGF-β1-induced apoptosis and EMT. The results indicate that PKA is an upstream regulator for TGF-β1-induced STAT3 activation and plays an important role in TGF-β1-mediated apoptosis and EMT. These studies provided a new insight into the signaling mechanism underlying the apoptosis and EMT, which could be of importance in understanding some related physiologic and pathologic processes.",
author = "Yanan Yang and Xinchao Pan and Weiwei Lei and Jun Wang and Jian Shi and Fuqiang Li and Jianguo Song",
year = "2006",
month = "9",
day = "1",
doi = "10.1158/0008-5472.CAN-06-1308",
language = "English (US)",
volume = "66",
pages = "8617--8624",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Regulation of transforming growth factor-β1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3

AU - Yang, Yanan

AU - Pan, Xinchao

AU - Lei, Weiwei

AU - Wang, Jun

AU - Shi, Jian

AU - Li, Fuqiang

AU - Song, Jianguo

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Apoptosis and epithelial-to-mesenchymal transdifferentiation or transition (EMT) are crucial for normal development and body homeostasis. The alterations of these events are closely related to some pathologic processes, such as tumor formation and metastasis, fibrotic diseases of liver and kidney, and abnormal development of embryos. The mechanism that underlies the simultaneously occurring apoptosis and EMT induced by transforming growth factor-β (TGF-β) has not been well studied. In this report, we investigated the potential mechanism that underlies TGF-β1-induced apoptosis and EMT. TGF-β1-induced apoptosis and EMT were associated with the activation of protein kinase A (PKA) and signal transducers and activators of transcription 3 (STAT3). Inhibition of PKA by specific PKA inhibitor H89 or by PKA inhibitor peptide blocked STAT3 activation and suppressed TGF-β1-induced apoptosis and EMT. Furthermore, overexpression of a phosphorylation-deficient form of STAT3, but not wild-type STAT3, produced an inhibitory effect on TGF-β1-induced apoptosis and EMT. The results indicate that PKA is an upstream regulator for TGF-β1-induced STAT3 activation and plays an important role in TGF-β1-mediated apoptosis and EMT. These studies provided a new insight into the signaling mechanism underlying the apoptosis and EMT, which could be of importance in understanding some related physiologic and pathologic processes.

AB - Apoptosis and epithelial-to-mesenchymal transdifferentiation or transition (EMT) are crucial for normal development and body homeostasis. The alterations of these events are closely related to some pathologic processes, such as tumor formation and metastasis, fibrotic diseases of liver and kidney, and abnormal development of embryos. The mechanism that underlies the simultaneously occurring apoptosis and EMT induced by transforming growth factor-β (TGF-β) has not been well studied. In this report, we investigated the potential mechanism that underlies TGF-β1-induced apoptosis and EMT. TGF-β1-induced apoptosis and EMT were associated with the activation of protein kinase A (PKA) and signal transducers and activators of transcription 3 (STAT3). Inhibition of PKA by specific PKA inhibitor H89 or by PKA inhibitor peptide blocked STAT3 activation and suppressed TGF-β1-induced apoptosis and EMT. Furthermore, overexpression of a phosphorylation-deficient form of STAT3, but not wild-type STAT3, produced an inhibitory effect on TGF-β1-induced apoptosis and EMT. The results indicate that PKA is an upstream regulator for TGF-β1-induced STAT3 activation and plays an important role in TGF-β1-mediated apoptosis and EMT. These studies provided a new insight into the signaling mechanism underlying the apoptosis and EMT, which could be of importance in understanding some related physiologic and pathologic processes.

UR - http://www.scopus.com/inward/record.url?scp=33749004556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749004556&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-1308

DO - 10.1158/0008-5472.CAN-06-1308

M3 - Article

C2 - 16951175

AN - SCOPUS:33749004556

VL - 66

SP - 8617

EP - 8624

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 17

ER -